The effect of probiotic and or prebiotic on liver function tests in patients with nonalcoholic fatty liver disease : a double blind randomized clinical trial

المؤلفون المشاركون

Javadi, Layla
Ghavami, Mustafa
Khoshbaten, Manouchehr
Barzegari, Abu al-Fadl
Gargari, Bahram Pourghassem
Safaiyan, Abd al-Rasul

المصدر

Iranian Red Crescent Medical Journal

العدد

المجلد 19، العدد 4 (30 إبريل/نيسان 2017)، ص ص. 1-9، 9ص.

الناشر

المستشفى الإيراني

تاريخ النشر

2017-04-30

دولة النشر

الإمارات العربية المتحدة

عدد الصفحات

9

التخصصات الرئيسية

الطب البشري

الملخص EN

Background: Oral administration of pro- and prebiotics has recently been considered as an effective way for nonalcoholic fatty liver disease (NAFLD) recovery.

Objectives: The current study aimed at evaluating the effect of supplementation with probiotics and/or prebiotics on liver function tests in patients with NAFLD.

Methods: In this double blind, placebo-control clinical trial, 75 subjects with NAFLD were voluntarily recruited from May 2013 to March 2014, in Iran.

Participants were randomly assigned to 1 of 4 groups using a block randomization procedure.

Group 1 received probiotic capsules (Bifidobacterium longum (BL) and Lactobacillus acidophilus (LA): 2 107 CFU/day), group 2 received prebiotic inulin high performance (HP): 10 g/day, group 3 received probiotic and the prebiotic, and group 4 received a placebo for 3 months.

The sample size was determined on the basis of a primary outcome of a change in aspartate aminotransferase (AST) level.

Results: Anintergroup comparison indicated that the AST (P = 0.006) and alanine aminotransferase (ALT) (P = 0.04) levels decreased at the end of the study.

Aspartate Aminotransferase (mean difference of group1 versus placebo with P value of 0.001, group2 versus placebo with P value of 0.045, group3 versus placebo with P value of 0.015) and ALT (mean difference of group 1 versus placebo with P value of 0.009, group 2 versus placebo with P value of 0.041, and group 3 versus placebo with P value of 0.046) serum levels decreased significantly in all of the intervention groups compared to the placebo.

The grade of fatty liver in group 1 (P of 0.027, and number needed to treat (NNT) = 3) and group 3 (P = 0.019 and NNT = 3) decreased compared to the placebo group with no significant changes in group 2.

Conclusions: Supplementation with probiotics and/or prebiotics improvedaminotransferase enzymes, andsupplementation with probiotics or pro- and prebiotics recovered the grade of fatty liver in NAFLD patients.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Javadi, Layla& Ghavami, Mustafa& Khoshbaten, Manouchehr& Safaiyan, Abd al-Rasul& Barzegari, Abu al-Fadl& Gargari, Bahram Pourghassem. 2017. The effect of probiotic and or prebiotic on liver function tests in patients with nonalcoholic fatty liver disease : a double blind randomized clinical trial. Iranian Red Crescent Medical Journal،Vol. 19, no. 4, pp.1-9.
https://search.emarefa.net/detail/BIM-820696

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Javadi, Layla…[et al.]. The effect of probiotic and or prebiotic on liver function tests in patients with nonalcoholic fatty liver disease : a double blind randomized clinical trial. Iranian Red Crescent Medical Journal Vol. 19, no. 4 (Apr. 2017), pp.1-9.
https://search.emarefa.net/detail/BIM-820696

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Javadi, Layla& Ghavami, Mustafa& Khoshbaten, Manouchehr& Safaiyan, Abd al-Rasul& Barzegari, Abu al-Fadl& Gargari, Bahram Pourghassem. The effect of probiotic and or prebiotic on liver function tests in patients with nonalcoholic fatty liver disease : a double blind randomized clinical trial. Iranian Red Crescent Medical Journal. 2017. Vol. 19, no. 4, pp.1-9.
https://search.emarefa.net/detail/BIM-820696

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references : p. 8-9

رقم السجل

BIM-820696